戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 644作成日:2026年10月23日

1-Bromo-4-iodobenzene → 2-(4-Bromophenyl)-1,3-dihydroisoindole

https://huagongshe.com/ja/reaction/644

反応式

関与物質

役割名称HCID仕込み量
反応物1-Bromo-4-iodobenzeneHCID 11522—
反応物IsoindolineHCID 422478—
試薬Sodium t-butoxideHCID 23676156—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Palladium (II) acetateHCID 4144353—
溶媒TolueneHCID 1140—
生成物2-(4-Bromophenyl)-1,3-dihydroisoindoleHCID 371387848.3%

反応条件

温度100 °C

反応手順

palladium(II) acetate (0.112 g, 0.50 mmol) and XANTPHOS (0.288 g, 0.50 mmol) were added to a degassed solution of isoindoline (0.566 ml, 4.98 mmol), 1-bromo-4-iodobenzene (1.41 g, 4.98 mmol) and SODIUM TERT-BUTOXIDE (1.197 g, 12.46 mmol) in toluene (49.3 ml) under nitrogen. The resulting solution was stirred at 100 °C for 18 hours. The reaction mixture was allowed to cool to RT and was partitioned between EtOAc and H2O, filtered and the organic layer separated and dried over MgSO4, filtered and evaporated to dryness to give crude product. The crude product preabsorbed onto SiO2 and was purified by flash silica (40g, grace) chromatography, elution gradient 0 to 10% DCM in heptane. Pure fractions were evaporated to dryness to afford 2-(4-bromophenyl)isoindoline (0.660 g, 48.3 %) as an orange solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-be64b42a88614cc79bed55017a7f5289
出典メモ750 AstraZeneca ELN dataset